Cyprus vs Trinidad and Tobago: Statin use vs average non hdl cholesterol levels
Cyprus
3.5
in 2018
Trinidad and Tobago
3.5
in 2018
Cyprus rank
51st
Trinidad and Tobago rank
51st
Statin use vs average non hdl cholesterol levels over time
- Cyprus
- Trinidad and Tobago
How they compare
Cyprus currently reports 3.5 against 3.5 in Trinidad and Tobago, a difference of 0.
The two have swapped places 1 time across 39 shared years of data; in 1980 it was Cyprus ahead.
Cyprus ranks 51st and Trinidad and Tobago ranks 51st of 189 countries.
Cyprus has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Cyprus | Trinidad and Tobago | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 4.2 | 3.5 | 0.7 | Cyprus |
| 1990s | 4.04 | 3.47 | 0.57 | Cyprus |
| 2000s | 3.79 | 3.42 | 0.37 | Cyprus |
| 2010s | 3.62 | 3.5 | 0.1222 | Cyprus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher statin use vs average non hdl cholesterol levels, Cyprus or Trinidad and Tobago?
- Cyprus, at 3.5 against 3.5 in Trinidad and Tobago as of 2018.
- What is the difference in statin use vs average non hdl cholesterol levels between Cyprus and Trinidad and Tobago?
- 0, with Cyprus ahead.
- How many years of comparable data are there for Cyprus and Trinidad and Tobago?
- 39 years are reported by both, from 1980 to 2018.
- How do Cyprus and Trinidad and Tobago rank globally for statin use vs average non hdl cholesterol levels?
- Cyprus ranks 51st and Trinidad and Tobago ranks 51st of 189 countries.
- Where does this data come from?
- Our World in Data, published as Statin use vs average non hdl cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.